These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9738057)

  • 21. Hepatitis C virus recombinants are rare even among intravenous drug users.
    Viazov S; Ross SS; Kyuregyan KK; Timm J; Neumann-Haefelin C; Isaeva OV; Popova OE; Dmitriev PN; El Sharkawi F; Thimme R; Michailov MI; Roggendorf M
    J Med Virol; 2010 Feb; 82(2):232-8. PubMed ID: 20029799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors.
    Attia MA; Zekri AR; Goudsmit J; Boom R; Khaled HM; Mansour MT; de Wolf F; el-Din HM; Sol CJ
    J Clin Microbiol; 1996 Nov; 34(11):2665-9. PubMed ID: 8897161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on applicability of hepatitis C virus serotyping].
    Zhang T; Zhang S; Gao P
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec; 15(4):355-6. PubMed ID: 11986725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotyping and genotyping of hepatitis C virus in Belgium.
    De Cock L; Vranckx R
    Infection; 2003 Mar; 31(2):92-7. PubMed ID: 12682814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam.
    Tanimoto T; Nguyen HC; Ishizaki A; Chung PT; Hoang TT; Nguyen VT; Kageyama S; Oka S; Pham VT; Ichimura H
    J Med Virol; 2010 Aug; 82(8):1355-63. PubMed ID: 20572071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
    Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
    J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Typing of hepatitis C virus antibody with specific peptides in seropositive blood donors and comparison with genotyping of viral RNA.
    León P; López JA; Elola C; Quan S; Echevarría JM
    Vox Sang; 1997; 72(2):71-5. PubMed ID: 9088072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
    Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
    Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotyping and genotyping of hepatitis C virus in Taiwanese patients with type C chronic liver disease and uraemic patients on maintenance haemodialysis.
    Yu ML; Wang LY; Chuang WL; Dai CY; Sung MH; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Chang WY
    J Gastroenterol Hepatol; 2000 Jul; 15(7):792-7. PubMed ID: 10937687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong.
    Prescott LE; Simmonds P; Lai CL; Chan NK; Pike I; Yap PL; Lin CK
    J Med Virol; 1996 Oct; 50(2):168-75. PubMed ID: 8915883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Genotype 2 HCV in Serotype-1 Hepatitis C Patients Unresponsive to Daclatasvir plus Asunaprevir Treatment.
    Inoue J; Kanno A; Wakui Y; Miura M; Kobayashi T; Morosawa T; Kogure T; Kakazu E; Ninomiya M; Fujisaka Y; Umetsu T; Takai S; Nakamura T; Shimosegawa T
    Tohoku J Exp Med; 2017 Jan; 241(1):21-28. PubMed ID: 28049871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Usefulness of hepatitis C virus (HCV) genotype test using direct sequencing of 5' untranslated region--application from 2003 to 2011].
    Maruo R; Sato Y; Yokota H; Kageyama Y; Syukuya K; Yatomi Y
    Rinsho Byori; 2012 Oct; 60(10):927-31. PubMed ID: 23323457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance.
    Merat SJ; Bru C; van de Berg D; Molenkamp R; Tarr AW; Koekkoek S; Kootstra NA; Prins M; Ball JK; Bakker AQ; de Jong MD; Spits H; Beaumont T; Schinkel J
    J Hepatol; 2019 Jul; 71(1):14-24. PubMed ID: 30797052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of hepatitis C virus isolates using molecular and serological typing methods.
    Cretel E; Gallian P; Obadia Y; Rousseau S; de Micco P; de Lamballerie X
    Acta Virol; 1997 Oct; 41(5):269-75. PubMed ID: 9607080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two successive hepatitis C virus infections in an intravenous drug user.
    Proust B; Dubois F; Bacq Y; Le Pogam S; Rogez S; Levillain R; Goudeau A
    J Clin Microbiol; 2000 Aug; 38(8):3125-7. PubMed ID: 10921996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Variants of hepatitis C virus in different risk groups. Comparative study of a method for genotyping and another for serotyping].
    Alonso P; Orduña A; San Miguel A; Gutiérrez MP; Lorenzo B; Eiros JM; Bratos MA; Cuervo M; Rodríguez Torres A
    Enferm Infecc Microbiol Clin; 1998 Mar; 16(3):111-7. PubMed ID: 9611871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serologically defined genotypes of hepatitis C virus among Japanese patients with chronic hepatitis C.
    Mizoguchi N; Mizokami M; Orito E; Shibata H; Shibata H
    J Virol Methods; 1996 Apr; 58(1-2):71-9. PubMed ID: 8783152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of hepatitis C virus genotypes among intravenous drug users. A ten-year study in Palermo, Sicily.
    Vitale F; Villafrate MR; Viviano E; Perna AM; Bonura F; Di Benedetto MA; Mazzola G; Colletti P; Prestileo T; Romano N
    New Microbiol; 1998 Oct; 21(4):335-42. PubMed ID: 9812314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmission dynamics of hepatitis C virus among intra venous drug users in the border state of Manipur, India.
    Saha K; Firdaus R; Biswas A; Mukherjee A; Sarkar K; Chakrabarti S; Sadhukhan PC
    Infect Genet Evol; 2014 Jun; 24():57-67. PubMed ID: 24650917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunoreactivity profile of different HCV genotypes on immunoblot assay and its implications in the development of diagnostic assays.
    Kanistanon D; Neelamek M; Dharakul T; Songsivilai S
    Asian Pac J Allergy Immunol; 1997 Sep; 15(3):133-40. PubMed ID: 9438545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.